Patients with cardiovascular disease should continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) as prescribed if they are diagnosed with the new coronavirus (COVID-19), according to a joint statement from three medical societies.
The president of the American Society of Nuclear Cardiology said there are no shortfalls reported at this time, but the organization is keeping an eye on the situation as more countries implement travel bans.
Long-term daily exposure to air pollution carrying fine particulate matter poses a significant risk of all-cause mortality for people with heart failure (HF).
Heart patients with implanted left ventricular assist devices are more likely to both attempt and succeed in committing suicide than other chronically ill patients, according to a study out of France.
To get the operational perspective, CVB hosted a roundtable discussion with service line leaders about the opportunities and challenges they encounter around data.
A California judge is recommending that a University of California, Los Angeles cardiologist accused of sexually assaulting three women have his medical license revoked.
Tom Giangiulio Jr. and his wife, Carin, celebrate his 58th birthday on June 6, 2017, two weeks before Giangiulio received a transplant with a Hepatitis C-infected heart.
As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.
New York-based digital health company Heartbeat Health announced March 12 that it had closed $8.2 million in Series A funding led by .406 Ventures, Optum Ventures and existing investors.
